Integrating Project YES! With WHO-Endorsed Mental Health Approaches Among Youth Living With HIV

NCT07221201 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-11-24

No results posted yet for this study

Summary

The proposed study will address the intersecting stigmas of HIV, violence and depression among adolescents and young adults (15-24) living with HIV (AYALHIV) in Zambia. The study will integrate a WHO-endorsed mental health approach into an existing HIV-stigma-reducing intervention, and refine measures of internalized and intersecting stigmas, to create and test the feasibility of Project YES+- a combined youth peer mentoring and lay mental health intervention. This research aims to shift HIV care and treatment for AYALHIV by addressing the multiple internalized and intersecting stigmas that impeded antiretroviral adherence and HIV viral suppression.

Conditions

Interventions

BEHAVIORAL

Project YES+ intervention arm

Project YES+ integrates Project YES!

Sponsors & Collaborators

  • Fogarty International Center of the National Institute of Health

    collaborator NIH
  • Arthur Davison Children's Hospital

    collaborator OTHER
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Principal Investigators

  • Julie A Denison, PhD · JHBSPH

  • Sam Miti, BSc HB, MBcHB, MeMMed-PEDS · Arthur Davison Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-25
Primary Completion
2026-06-15
Completion
2026-06-30

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07221201 on ClinicalTrials.gov